This website uses cookies

To give you the best possible experience, this site uses cookies. Continuing to use means you agree to our use of cookies. For more information about the cookies we use, please see our Cookie Policy.

Accept and Close

About Us

Cogniciti is the brain health subsidiary of Toronto-based Baycrest Health Sciences. Since its launch in 2014, Cogniciti’s Online Brain Health Assessment has shown exceptional user engagement, with over 63,000 assessments completed. Cogniciti aims to bring brain health solutions to people, businesses, and governments worldwide.

Our mission:

  • To help the millions of adults with significant memory concerns get earlier assessment, diagnosis and treatment;
  • To help the tens of millions of adults with normal memory loss find peace-of-mind and effective, science-validated coping tools;
  • To help family caregivers better support loved ones with dementia; and
  • To speed the development of the next generation of dementia prevention therapies and medications.

To do this, we offer free brain health workshops at senior’s centres, recruit for promising mild cognitive impairment (MCI) clinical research studies, and compile a vast research registry of motivated adults across Canada, the US and the UK.


About Baycrest Health Sciences

Now in its 100th year of operation, Baycrest Health Sciences is an established global leader in geriatric healthcare, research, innovation and education. It is Canada’s largest geriatric hospital, North America’s largest geriatrics training institute, and a world leader in the research of memory and aging. It is also home to the Rotman Research Institute, one of the world’s leaders in cognitive neuroscience.

About MaRS Discovery District

MaRS Discovery District in Toronto is a Canadian leader in converting science and technology research into practical solutions. It is one of the world’s largest urban innovation hubs supporting a new generation of makers and innovators who aim to create solutions that address key societal challenges. In the last three years, MaRS ventures have raised $1.3 billion in capital and earned $640 million in revenue.

Ma RS2
Cogniciti - Brain Health Powered by Science